TY - JOUR
T1 - Daytime somnolence and night sleep disturbances in Parkinson's disease
T2 - Background and future treatment prospective
AU - Antonini, Angelo
PY - 2007/1
Y1 - 2007/1
N2 - Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.
AB - Sleep abnormalities are common in patients with Parkinson's disease (PD). Current clinical evidence suggests that both daytime somnolence and night-time sleep abnormalities are related mainly to worsening disease. Improvements in drug delivery, such as transdermal patch, allow more stable dopaminergic stimulation throughout the day. This approach might prove beneficial also for nonmotor symptoms and particularly helpful in improving sleep architecture in PD.
KW - Daytime somnolence
KW - Dopaminergic treatment
KW - Parkinson's disease
KW - Sleep abnormalities
UR - http://www.scopus.com/inward/record.url?scp=33846499541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846499541&partnerID=8YFLogxK
U2 - 10.1007/s10072-007-0732-1
DO - 10.1007/s10072-007-0732-1
M3 - Article
AN - SCOPUS:33846499541
VL - 28
JO - Neurological Sciences
JF - Neurological Sciences
SN - 1590-1874
IS - SUPL.1
ER -